hello, world! Short-tweet. Monumental progress.
— Thomas Oxley (@tomoxl) December 23, 2021
On the one hand, Neuralink is working on a device that it wants to embed in people's brains to monitor and potentially stimulate brain activity. On the other hand, Synchron is developing a neural interface device, which accesses the brain through blood vessels.
“Accessing the brain through blood vessels is an elegant idea, and after 10 years of work @synchroninc recently announced results from their first human patients; a great achievement. I'm excited to get involved as an investor as they move from the bank to bed," wrote Max Hodak on his Twitter account.
Accessing the brain via blood vessels is an elegant idea, and after 10y of work @synchroninc recently announced results from their first human patients; a huge accomplishment.
— Max Hodak (@maxhodak_) February 4, 2022
I'm excited to get involved as an investor as they go from bench to bedside.https://t. co/Lwo0M3T46T
Comentarios
Para comentar debes iniciar sesión